HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$7.46
Day range
$7.12 - $7.46
Year range
$5.35 - $49.27
Market cap
25.66M USD
Avg Volume
64.81K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.92M | 85.23% |
Net income | -13.81M | -84.47% |
Net profit margin | — | — |
Earnings per share | -4.03 | 8.82% |
EBITDA | -13.87M | -86.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.27M | -22.84% |
Total assets | 41.49M | -19.60% |
Total liabilities | 22.36M | -9.96% |
Total equity | 19.13M | — |
Shares outstanding | 3.50M | — |
Price to book | 1.32 | — |
Return on assets | -92.39% | — |
Return on capital | -109.27% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -13.81M | -84.47% |
Cash from operations | -10.15M | -64.36% |
Cash from investing | -3.00K | 57.14% |
Cash from financing | 17.95M | -47.74% |
Net change in cash | 7.80M | -72.31% |
Free cash flow | -4.89M | -31.67% |
About
Founded
2011
Headquarters
Website
Employees
24
